Laboratory Automation for Causal Studies of Qualitative Fibrinogen Phenotypes: A proposed framework for workflow selection validation and staged implementation

This conceptual methodological article proposes a framework for evaluating laboratory automation in causal studies of qualitative fibrinogen phenotypes. It asks which tasks warrant automation, how their performance should be validated, and when integration provides sufficient scientific and operational value to justify adoption. The framework distinguishes task automation, robotic integration, and bounded autonomous experiment selection. Published automated clot-lysis assays, bioanalytical robotic systems, and autonomous protein-engineering platforms provide precedents without validating the proposed direct-plasmin fibrinogen workflow. Candidate applications include specimen identification, concentration matching, timed reagent delivery, kinetic reading, purification, depletion–reconstitution, and serial transfer. Each application is linked to controls for material preservation, recovery, associated proteins, carryover, actual reaction timing, and traceability. A prospective comparison of qualified manual and automated execution evaluates systematic bias, agreement, precision, failures, resource use, and cost per interpretable result. Particular emphasis is placed on preserving the experimental contrast: improved technical repeatability is insufficient if automation alters the molecular population or suppresses a relevant biological response. The article also distinguishes computational feedback from biological self-maintenance. A robotic controller that repeatedly transfers material or supplies mediators may externally sustain an experimental state and therefore cannot, by itself, demonstrate an endogenous maintenance circuit. Four tables summarize automation levels, candidate modules, validation requirements, and adoption decisions. Two appendices provide planning records for workflow selection and comparability assessment. No robotic platform has been tested within this program, and no original experimental results, performance gains, or cost savings are reported. The framework supports modular implementation conditioned on demonstrated value and does not make robotics a prerequisite for initiating qualified fibrinogen research.